Willis Towers Watson, GB00BGSZ2X45

Willis Towers Watson stock gains global Zurich deal as valuation stays modest

Published on 09/21/2026 at 15:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Willis Towers Watson stock is trading near USD 309.99 as of September 18, 2026 while a new global agreement with Zurich Insurance for Radar pricing software expands its reach. Q2 fiscal 2026 EPS rose 17% to USD 3.35 on 9.1% higher revenue, underscoring operating momentum.

Aquarell der Londoner Skyline mit Themse und warmem Abendlicht
Willis Towers Watson (GB00BGSZ2X45) inspiriert durch stimmungsvolles Aquarellbild der Londoner Finanzdistrikt-Skyline bei Sonnenuntergang am Fluss, Illustration mit AI erstellt.

Willis Towers Watson stock is drawing fresh attention after the group announced a new global agreement with Zurich Insurance to deploy its Radar pricing and analytics software, while the shares trade around USD 309.99 as of September 18, 2026, modestly below some valuation estimates. According to GuruFocus on September 21, 2026, Willis Towers Watson shares recently changed hands at about USD 309.99, roughly 7.4% below an intrinsic value estimate of USD 334.72 based on the GF Value metric.

Zurich global Radar deal strengthens growth story

On September 21, 2026, Willis Towers Watson plc announced that Zurich Insurance Company Limited will roll out the firm’s Radar end-to-end rating and analytics software across its target retail markets worldwide, extending an earlier country-level deployment. As Barchart reported on September 21, 2026, the London-headquartered advisory and broking group expects the expanded partnership to help Zurich improve pricing sophistication and risk selection across its global retail portfolio.

The deal positions Willis Towers Watson’s Radar platform more deeply within a major international carrier’s operations and underscores the firm’s push to scale its analytics-driven insurance technology. According to TradingView on September 21, 2026, the agreement moves Radar from a prior single-country implementation to a global rollout across Zurich’s retail markets, highlighting growing demand from large insurers for data-driven pricing systems.

Valuation and earnings: modest undervaluation with double-digit EPS growth

From a valuation perspective, some quantitative metrics point to modest upside. According to GuruFocus on September 21, 2026, Willis Towers Watson’s shares at USD 309.99 trade about 7.4% below the GF Value estimate of USD 334.72, suggesting what the platform characterizes as modest undervaluation. The same overview notes a trailing-twelve-month price-to-earnings ratio of 19.12 times, a shade under the firm’s five-year median P/E of 20.15 times, indicating the market is currently applying a slightly lower multiple than it has on average in recent years.

Recent operating results provide context for that valuation. In a sector comparison cited by 24/7 Wall St on September 21, 2026, Willis Towers Watson’s second quarter of fiscal 2026 delivered adjusted diluted EPS of USD 3.35, up 17% year over year, on revenue of USD 2.466 billion, which marked a 9.1% increase versus the prior-year quarter. The same piece notes that the adjusted operating margin expanded by 100 basis points to 19.5% in Q2 fiscal 2026, underscoring incremental profitability improvement alongside top-line growth.

That combination of mid single-digit to high single-digit revenue growth with double-digit EPS expansion and a rising operating margin helps explain why quantitative models and some market observers see room for further appreciation if execution continues. For investors, the spread between the current share price of roughly USD 309.99 and the GF Value estimate of USD 334.72 is one useful yardstick, while the 17% EPS growth against a 9.1% revenue gain in Q2 fiscal 2026 offers a concrete signal of operating leverage at work over the past year.

Dividend, segments and sector backdrop

Income-oriented holders have also had a reason to stay engaged. As Zonebourse reported on September 21, 2026, Willis Towers Watson has maintained its quarterly dividend at USD 0.96 per share, with the next payment scheduled for October 15, 2026 to shareholders of record as of September 30, 2026 and the ex-dividend date noted as September 30, 2026. That payout, when annualized, provides a visible cash-return component alongside the firm’s earnings and technology-driven growth initiatives.

Operationally, Willis Towers Watson remains a diversified advisory and broking platform with meaningful exposure to risk, human capital and benefits consulting. According to a sector overview on insurance stocks by Yahoo Finance dated September 20, 2026, the company generates about USD 4.54 billion of revenue from its Risk and Broking segment and roughly USD 5.44 billion from Health, Wealth and Career services, supplemented by smaller reimbursable items. That mix gives the stock exposure to corporate risk management, pensions and employee benefits trends as well as to broader geopolitical and marine insurance themes, which the same overview highlights as areas of investor interest in the current environment.

Against that backdrop of diversified cash flows and a growing technology footprint, the newly expanded Zurich agreement serves as a concrete example of how Willis Towers Watson aims to embed its analytics platforms deeper into insurer workflows. The Radar rollout across Zurich’s retail operations could, over time, support incremental licensing and services revenue and reinforce the firm’s positioning as a specialist in pricing sophistication, even though direct financial contributions from the contract have not yet been quantified in publicly available data.

Stock price context and trading reference

For now, the key reference level for Willis Towers Watson stock is the recent closing price around USD 309.99 on its Nasdaq listing as of September 18, 2026, which stands comfortably within the broader 52-week range cited in same-week coverage. Per data summarized in the Zonebourse overview on September 21, 2026, the stock’s last closing level was USD 309.98 on Nasdaq on September 18, 2026, with the five-day change showing a slight decline and the year-to-date move indicating a mid single-digit negative performance, while market consensus targets in that snapshot averaged about USD 378.58 per share.

That leaves the shares trading materially below those average analyst price expectations and a bit below some intrinsic value estimates, even after a period in which the stock has slipped 5.7% year to date and 6.6% over the past twelve months as noted by 24/7 Wall St on September 21, 2026. With the new Zurich agreement announced on September 21, 2026 and a solid Q2 fiscal 2026 showing of revenue and EPS growth, investors following Willis Towers Watson stock now have a fresh operational catalyst and a set of concrete numbers to weigh against the current trading level on Nasdaq.

Willis Towers Watson stock facts

  • Company: Willis Towers Watson plc
  • ISIN: GB00BGSZ2X45
  • Ticker: WTW
  • Trading venue: Nasdaq
  • Price (as of September 18, 2026): 309.99 USD
  • Market capitalization: [value] USD (as of September 18, 2026)
  • Sector / Industry: Insurance broking and advisory services
  • Index membership: S&P 500
  • Next earnings date: [Month D, YYYY]

More news and analyses on Willis Towers Watson stock

Disclaimer...

en | GB00BGSZ2X45 | WILLIS TOWERS WATSON | boerse | 70144910 | bgmi